Citrate Market – By Type , By Purity , By End Use Industry , and By Geography Analysis - Global Opportunity Analysis & Industry Forecast, 2025-2031
Citrate Market Overview
The Citrate Market is estimated to reach $1.4 Billion by 2031, growing at a CAGR of 4.7% from 2025 to 2031. Citrate is an intermediate in the Tricarboxylic Acid Cycle and is used by all aerobic organisms to produce usable chemical energy. It is a derivative of citric acid, a weak organic acid that can be introduced with diet since it naturally exists in various fruits and vegetables, and can be consumed as a dietary supplement. The growing demand in the food and beverage industry, the expanding use of citrates in pharmaceutical applications, and the steady growth of the healthcare sector are key factors driving the Citrate Market. According to the National Library of Medicine, Triethyl citrate as a compound form is used in food as a flavoring agent, solvent and surface-active agent Triethyl citrate is an ester of citric acid. It is a colorless, odorless liquid used as a food additive (E number E1505) to stabilize foams, especially as a whipping aid for egg whites in pharmaceutical coatings and plastics.
Citrate Market - Report Coverage:
The report: “Citrate Market – Forecast (2025-2031)” by IndustryARC, covers an in-depth analysis of the following segments of the Citrate Industry.
Attribute | Segment |
---|---|
By Type |
|
By Purity |
|
By End Use Industry |
|
By Geography |
|
Key Takeaways:
Potassium Citrate is the Largest Segment
Potassium Citrate holds the largest share in the global Citrate Market, driven by its versatile applications and health benefits. Widely used in the pharmaceutical industry, potassium citrate is essential in treating kidney stones and managing urinary alkalization. Its role in dietary supplements for maintaining electrolyte balance and supporting heart health further strengthened its demand. In the food and beverage sector, potassium citrate serves as a vital acidity regulator and preservative, particularly in beverages, dairy products, and processed foods. In 2024, the conference held by the American Urological Association in San Antonio revealed that urologists predominantly prescribed potassium citrate, which accounts for over 99% of claims and costs each year. Potassium Citrate is often prescribed for kidney stones as its effect reduces kidney stone formation. From 2013 to 2020, it was observed that spending on potassium citrate nearly doubled, rising from approximately $13.7 million to $27.2 million. The cost per claim for potassium citrate was significantly higher than other alternatives such as potassium bicarbonate, sodium citrate, and sodium bicarbonate. Additionally, its low-sodium profile makes it an ideal ingredient for health-conscious consumers seeking sodium-free alternatives. The rising widespread of chronic diseases, coupled with increasing consumer awareness about health and wellness, has cemented potassium citrate as a cornerstone of the Citrate Market.
>99% is the Largest Segment
The >99% purity grade dominates the Citrate Market, driven by its critical role in high-value applications. This pharmaceutical-grade purity is crucial for industries that demand exceptional quality, including pharmaceuticals, nutraceuticals, and specialty food products. High-purity citric acid and its salts are extensively used in dietary supplements, effervescent tablets, and injectable drugs due to their stringent safety and efficacy standards. According to Apollo Hospitals, the combination of citric acid and sodium citrate belongs to the "alkalinizing agents" class of medications, commonly used to prevent gout, and kidney stones, and treat metabolic acidosis in patients with kidney diseases. Citric acid works by binding with salts to prevent deposits from forming and breaking down into small deposits. Sodium citrate, once metabolized into sodium bicarbonate, acts as an alkaline agent, neutralizing acids in the blood and urine to prevent the accumulation of salts. These treatments should always follow a doctor’s prescription to minimize potential side effects. In the food and beverage sector, >99% purity ensures product stability and safety, making it a preferred choice for premium formulations. This grade also meets rigorous regulatory standards such as USP (United States Pharmacopeia) and EP (European Pharmacopoeia). The growing demand for high-purity citrates is further driven by their use in medical treatments and consumer health products, solidifying their dominant position in the market.
Asia-Pacific Leads the Market
Asia-Pacific’s region emerges as the leader, holding the majority market share of 34% in 2024. Asia-Pacific dominates the global Citrate Market, propelled by rapid industrialization, and the expanding pharmaceutical and food industries. China and India emerge as key players, leveraging their strong manufacturing capabilities and large consumer bases. The region's demand for citric acid and its derivatives is fuelled by their diverse applications in dietary supplements, processed foods, and effervescent tablets. In July 2024, United News of India highlighted West Bengal Chemical Industries as a rising force in the pharmaceutical sector. The company produces 10,000 MT of Active Pharmaceutical Ingredients (API) annually, serving over 4,000 clients across 20 countries, with innovations spanning 30+ nations. Its nine patents include advancements like a cost-effective process for Ferric Citrate and Ferric Derisomaltose, cementing its position in high-value markets. Growing health awareness and rising disposable incomes have further spurred demand for nutraceuticals, driving the consumption of high-purity citrates. Coupled with supportive government policies and stringent regulatory standards, Asia-Pacific continues to thrive as a global hub for citrate production, solidifying its leadership in the market.
The Rising Demand Natural and Environmentally Friendly Product to Drive the Market
The Citrate Market thrives due to its strong alignment with environmental and natural trends, positioning citric acid as a preferred choice across diverse industries. Naturally derived from citrus fruits or produced through microbial fermentation, citric acid is biodegradable, non-toxic, and eco-friendly. These characteristics make it highly appealing to consumers and manufacturers committed to sustainability and reducing environmental impact. In the cleaning and detergent sector, citric acid serves as a natural chelating agent, replacing harsh chemicals and lowering the environmental footprint of these products. Similarly, the food and beverage industry leverage citric acid for its natural preservative properties, catering to the rising demand for clean-label and organic products. The pharmaceutical industry also benefits from citrate's versatility, particularly in hemodialysis. According to a February 2024 report by Kidney International Reports, citrate has emerged as a greener alternative to heparin in hemodialysis. Citrate-enabled heparin-free dialysis works by binding ionized calcium (Ca), a key factor in blood clotting, and requires a calcium-free dialysis fluid along with calcium supplementation post-dialyzer. With a low carbon footprint, citrate significantly outperforms heparin in environmental impact. For instance, 13 four-hour dialysis sessions using citrate produce just 0.94 kg CO2 equivalent to less than 1.5% of the carbon footprint associated with heparin. Regulatory support and sustainability initiatives further enhance citric acid's appeal, as it adheres to stringent environmental standards. This natural, versatile compound continues to gain traction across industries focused on eco-friendly solutions, solidifying its role in the transition toward greener practices worldwide.
For More Details on This Report - Request for Sample
Citrate Market Key Players-
Product/Service launches, approvals, patents and events, acquisitions, partnerships, and collaborations are key strategies adopted by players in the Citrate Market. The top 10 players in the Citrate Market are:
- Gadot Biochemical Industries Ltd
- Jungbunzlauer Suisse AG
- Citrate
- ADM
- Tate & Lyle
- Saudi Aramco
- Citrique Belge
- Huangshi Xinghua Biochemical Co., Ltd
- RZBC Group Co., Ltd
- Weifang Ensign Industry Co., Ltd.
Scope of the Report:
Report Metric | Details |
---|---|
Base Year Considered |
2024 |
Forecast Period |
2025–2031 |
CAGR |
4.7% |
Market Size in 2031 |
$1.4 Billion |
Segments Covered |
By Type, By Purity, By End Use Industry, and By Geography |
Geographies Covered |
North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa). |
Key Market Players |
1. Gadot Biochemical Industries Ltd 2. Jungbunzlauer Suisse AG 3. Citrate 4. ADM 5. Tate & Lyle 6. Saudi Aramco 7. Citrique Belge 8. Huangshi Xinghua Biochemical Co., Ltd 9. RZBC Group Co., Ltd 10. Weifang Ensign Industry Co., Ltd. |
For more Chemicals and Materials Market reports, please click here
The Citrate Market is projected to grow at 4.7% CAGR during the forecast period 2025-2031.
The Citrate Market size is estimated to be $0.8 billion in 2024 and is projected to reach $1.4 Billion by 2031.
The leading players in the Citrate Market are Gadot Biochemical Industries Ltd, Jungbunzlauer Suisse AG, Citrate, ADM, and Tate & Lyle.
Key trends shaping the Citrate Market include the growing demand for clean-label products, an increased focus on health and wellness, a stronger emphasis on sustainability and eco-friendly solutions, and advancements in production technologies.
The Citrate Market is driven by several key factors, including increasing health consciousness, which fuels demand for nutraceuticals and functional foods. The growing food and beverage industry, along with the rising use of citrates in pharmaceuticals for applications like effervescent tablets and metabolic treatments, further propels market growth.